Archer Investment Corporation’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.3K Hold
1,000
0.02% 459
2026
Q1
$64.6K Hold
1,000
0.01% 488
2025
Q4
$67.3K Hold
1,000
0.02% 434
2025
Q3
$73.3K Hold
1,000
0.02% 430
2025
Q2
$52K Hold
1,000
0.01% 468
2025
Q1
$63.8K Hold
1,000
0.02% 430
2024
Q4
$47.8K Hold
1,000
0.01% 451
2024
Q3
$57.2K Hold
1,000
0.02% 422
2024
Q2
$52.4K Hold
1,000
0.02% 421
2024
Q1
$40.7K Hold
1,000
0.01% 433
2023
Q4
$37K Hold
1,000
0.01% 445
2023
Q3
$38.2K Hold
1,000
0.01% 419
2023
Q2
$36.1K Hold
1,000
0.01% 423
2023
Q1
$38.2K Hold
1,000
0.01% 416
2022
Q4
$56.9K Hold
1,000
0.02% 341
2022
Q3
$39.5K Hold
1,000
0.02% 371
2022
Q2
$44K Hold
1,000
0.02% 360
2022
Q1
$41.4K Hold
1,000
0.01% 387
2021
Q4
$40.2K Hold
1,000
0.01% 396
2021
Q3
$40.7K Hold
1,000
0.02% 383
2021
Q2
$45.4K Hold
1,000
0.02% 336
2021
Q1
$41.7K Hold
1,000
0.02% 366
2020
Q4
$42.7K Hold
1,000
0.02% 301
2020
Q3
$26.3K Hold
1,000
0.01% 335
2020
Q2
$26.8K Hold
1,000
0.02% 316
2020
Q1
$18K Hold
1,000
0.01% 359
2019
Q4
$18K Hold
1,000
0.01% 396
2019
Q3
$16K Hold
1,000
0.01% 306
2019
Q2
$17K Hold
1,000
0.01% 304
2019
Q1
$16K Hold
1,000
0.01% 306
2018
Q4
$15K Buy
+1,000
New +$16K 0.01% 297

Other funds holding HALO

Archer Investment Corporation's HALO Position: Q2 2026 in Review

Archer Investment Corporation held its Halozyme (HALO) position steady in Q2 2026 at 1,000 shares worth $78.3K. The position accounts for 0.02% of the portfolio, ranked #459.

Archer Investment Corporation first reported a position in HALO in Q4 2018 and has held it in 31 quarters since. 456 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Archer Investment Corporation held 1,000 shares of Halozyme worth $78.3K as of Q2 2026.
  • Archer Investment Corporation left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up 0.02% of Archer Investment Corporation's portfolio in Q2 2026, its #459 holding.
  • Archer Investment Corporation first reported a position in Halozyme in Q4 2018 and has held it in 31 quarters since.
  • 456 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.